Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 1.2015
Andrew D. Zelenetz(Memorial Sloan Kettering Cancer Center), Hema Sundar, Joachim Yahalom, Leo I. Gordon(Northwestern University), Nancy L. Harris(Digital Research Alliance of Canada), Nadeem Zafar(University of Tennessee Health Science Center), Oliver W. Press(Cancer Research Center), Thomas M. Habermann(Mayo Clinic), Luis Fayad(The University of Texas MD Anderson Cancer Center), Rachel Rabinovitch(University of Colorado Boulder), Susan Krivacic(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Erin Reid(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Lubomir Sokol, Pierluigi Porcu(Peter MacCallum Cancer Centre), Ranjana H. Advani(Stanford University), Christina Tsien(University of Michigan), Charalambos Andreadis(University of California, San Francisco), Steven M. Horwitz(Memorial Sloan Kettering Cancer Center), Richard T. Hoppe(Stanford University), Nancy L. Bartlett(Washington University in St. Louis), Julie M. Vose, Nishitha Reddy(Vanderbilt University), Ann S. LaCasce(Otsuka (Japan)), Ayman Saad(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Youn H. Kim(Cancer Prevention Institute of California), William G. Wierda(The University of Texas MD Anderson Cancer Center), John C. Byrd(The Ohio State University), Lynn D. Wilson(The University of Texas MD Anderson Cancer Center), Myron S. Czuczman(Roswell Park Comprehensive Cancer Center), Richard I. Fisher(University of Rochester), Mary A. Dwyer(National Comprehensive Cancer Network), Auayporn Nademanee(City Of Hope National Medical Center), Martha Glenn(Huntsman Cancer Institute), Jeremy S. Abramson(Harvard University), Lode J. Swinnen(Johns Hopkins University), Chris R. Kelsey(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute)
Cited by 78
Related Papers
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
|Blood|2009|4.4k
The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma
|New England Journal of Medicine|2002|3.9k
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
|New England Journal of Medicine|2018|2.3k
Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2013|2.2k